Your browser doesn't support javascript.
loading
Reply to 'Comment on 'Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy''.
Bowyer, Samantha; Prithviraj, Prashanth; Lorigan, Paul; Larkin, James; McArthur, Grant; Atkinson, Victoria; Millward, Michael; Khou, Muoi; Diem, Stefan; Ramanujam, Sangeetha; Kong, Ben; Liniker, Elizabeth; Guminski, Alexander; Parente, Phillip; Andrews, Miles C; Parakh, Sagun; Cebon, Jonathan; Long, Georgina V; Carlino, Matteo S; Klein, Oliver.
Afiliação
  • Bowyer S; Rockingham General Hospital, Perth, Western Australia, Australia.
  • Prithviraj P; School of Medicine and Pharmacology, University of Western Australia, Nedlands, Western Australia, Australia.
  • Lorigan P; Department of Medical Oncology, Olivia Newton-John Cancer Centre, Austin Hospital, Melbourne, Victoria, Australia.
  • Larkin J; Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia.
  • McArthur G; The Christie NHS Foundation Trust and University of Manchester, Manchester, UK.
  • Atkinson V; Royal Marsden Hospital NHS Foundation Trust, London, UK.
  • Millward M; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Khou M; Princess Alexandra Hospital, Greenslopes Private Hospital, Brisbane, Queensland, Australia.
  • Diem S; School of Medicine and Pharmacology, University of Western Australia, Nedlands, Western Australia, Australia.
  • Ramanujam S; Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.
  • Kong B; Westmead Hospital, Sydney, New South Wales, Australia.
  • Liniker E; Royal Marsden Hospital NHS Foundation Trust, London, UK.
  • Guminski A; Melanoma Institute Australia, Sydney, New South Wales, Australia.
  • Parente P; Westmead Hospital, Sydney, New South Wales, Australia.
  • Andrews MC; Melanoma Institute Australia, Sydney, New South Wales, Australia.
  • Parakh S; Melanoma Institute Australia, Sydney, New South Wales, Australia.
  • Cebon J; Box Hill Hospital, Melbourne, Victoria, Australia.
  • Long GV; Department of Medical Oncology, Olivia Newton-John Cancer Centre, Austin Hospital, Melbourne, Victoria, Australia.
  • Carlino MS; Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia.
  • Klein O; Department of Medical Oncology, Olivia Newton-John Cancer Centre, Austin Hospital, Melbourne, Victoria, Australia.
Br J Cancer ; 116(8): e15, 2017 04 11.
Article em En | MEDLINE | ID: mdl-28324885
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Melanoma Limite: Humans Idioma: En Revista: Br J Cancer Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Melanoma Limite: Humans Idioma: En Revista: Br J Cancer Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Austrália